English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 6 April 2021, 13:29 HKT/SGT

Source: Avantor
Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021
Company recognized for helping transform biologics production

Singapore, Apr 6, 2021 - (ACN Newswire) - Avantor Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, was named Best Bioprocessing Supplier in Single-Use Manufacturing at the Asia-Pacific Bioprocessing Excellence Awards 2021 held recently.

The award recognizes Avantor's contributions in facilitating biomanufacturing excellence with enhanced speed, reduced cost and superior quality, and reaffirms its critical role in biomanufacturing of biologics. Avantor was also awarded Best Company in Bioprocessing Excellence for Single-use Solutions at Biologics Manufacturing Korea 2020.

Narayana Rao Rapolu, Vice President, Biopharma Asia Middle East & Africa for the Company said, "Avantor has long been an open-architecture, single-use provider, offering complete design, manufacturing and logistics to support every stage of the biomanufacturing process. Our work in biopharma has never been more important. From the small-scale bench, to pilot plant and full commercial manufacturing, we enable our customers to reach the market with new treatments for patients - faster, safer and smarter."

Significance of single-use technologies:
- Robust and scalable, enabling transformative treatments to reach more patients globally.
- According to BioPharm International, a publication that integrates the science and business of biopharmaceuticals, single-use technologies are used in nearly 85% of pre-commercial manufacturing of biologics.
- Applications of biologics include monoclonal antibodies (mAbs) used in therapeutic solutions for immune-oncology and immunotherapy and cell and gene therapies which help to treat challenging illnesses, such as some cancers and genetic diseases.

For more information about Avantor's single-use solutions for biopharma manufacturing, watch this video: https://youtu.be/mfjZEfO_RVM.

About Avantor

Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.

For information, visit avantorsciences.com and find us on:
LinkedIn: https://www.linkedin.com/company/avantorinc/
Twitter: https://twitter.com/Avantor_News
Facebook: https://www.facebook.com/Avantorinc/

About Asia-Pacific Bioprocessing Excellence Award 2021 (ABEA)

The Asia-Pacific Bioprocessing Excellence Awards seeks to give recognition to exceptional bioprocessing experts, organizations and technologies that facilitate biomanufacturing excellence with enhanced speed, reduced cost, and superior quality. 2021 marks the fifth year of ABEA, which was first established in 2017 and backed by industry requests.

AMEA Media Contact
Christina Koh
Director - Communications, AMEA
Phone: +65 9170 0169
Email: [email protected]

Source: Avantor and Financial News

Topic: Press release summary
Source: Avantor

Sectors: BioTech, Healthcare & Pharm, MedTech
From the Asia Corporate News Network

Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Avantor Links






Latest Press Releases
Better memristors for brain-like computing  
May 15, 2021 07:00 HKT/SGT
E-House's open strategy to acquire an 85% stake in Tmall Haofang  
May 14, 2021 17:00 HKT/SGT
Eisai and National Cancer Center Commence Joint Research and Development Project   
May 14, 2021 16:48 HKT/SGT
TOYOTA GAZOO Racing Leads the WRC onto Gravel  
May 14, 2021 16:04 HKT/SGT
Hitachi ABB Power Grids enables Minnesota Power to deliver more clean and affordable hydropower to the U.S. Upper Midwest region  
May 14, 2021 14:24 HKT/SGT
Man Wah FY2021 Revenue from Main Business Up 35% to HK$16.4 Billion Despite Harsh Market Conditions, Net Profit Rises to HK$1.92 Billion  
May 14, 2021 14:22 HKT/SGT
NEC X and Alchemist Accelerator Announce Partnership to Speed Successful Startup Launches  
May 14, 2021 13:02 HKT/SGT
Commodities Intelligence Centre and ZALL Group Wins Gold and Silver Awards at The 2021 Asia-Pacific Stevie Awards  
May 14, 2021 10:00 HKT/SGT
President Xi Jinping reiterates the country's support for Traditional Chinese Medicine  
May 13, 2021 22:04 HKT/SGT
Shineway (2877.HK) Q1 revenue increased by 37.0%  
May 13, 2021 21:55 HKT/SGT
More Press release >>
More events >>
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575